In conclusion, our data suggested that HLA-DRB1 genetic polymorphism affects the expression of anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF) in rheumatoid arthritis (RA) patients. Here, HLA-DRB1 is linked to rheumatoid arthritis.